SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp selloff across AI neocloud stocks, fueled by concerns about financing costs and whether the sectors business models can deliver returns, has put NBIS in focus. Traders are split between viewing the drop as an overdone, oversold pullbackwith some citing NBISs stronger financial positionand expecting more downside amid lingering sector risks.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade to Buy has fueled a rebound discussion after a sharp selloff, with some traders seeing the decline as overdone and others warning that CoreWeaves heavy debt and financing needs remain a risk. The debate centers on whether AI demand and contracted business can outweigh concerns about borrowing costs and the companys ability to fund its expansion.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is drawing attention after stronger-than-expected third-quarter results and a sharply higher 2027 adjusted EBITDA outlook. Bulls are highlighting the improved outlook and potential short-covering, while skeptics question whether operating gains can ease the companys substantial debt burden.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The prolonged wait for the 80th death event in SELLASs blinded Phase 3 REGAL trialand the final analysis of its GPS treatment for AMLis driving attention amid share-price weakness. Bulls interpret the delay and upcoming ASH meeting as possible signs of extended survival or data disclosure, while skeptics say the timeline and CEOs comments prove nothing; no outcome has been confirmed, and traders also watch for SLS009 data.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

OCUL is drawing attention around AXPAXLIs prospects in wet AMD after competitor EyePoints trial setback. Some traders see fewer competitive threats and emphasize AXPAXLIs potential durability, while others argue the setback could fuel broader skepticism about TKI treatments; debate also centers on the companys pending NDA submission.

X-Energy, Inc. engages in the development of advanced small modular nuclear reactors and fuel technology for clean energy generation. Its solutions include Xe-100 and TRISO-X. The company was founded by Kam Ghaffarian and Eben Mulder in 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-Energy Inc

Traders are focused on XEs sharp post-IPO selloff, often blaming lockup-related share supply and weakness across nuclear and AI-linked stocks; concerns about the long path to commercialization and permitting also weigh on sentiment. Some holders remain bullish on Amazons backing and future data-center power demand, while others warn the selling may continue.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

The FDAs clearance to expand Alpha Taus U.S. REGAIN recurrent-glioblastoma trial from 10 to 20 patients is drawing attention, alongside expectations for additional clinical data at the SNO meeting. Traders are broadly optimistic about the growing catalyst pipeline, while the early GBM results come from a very small cohort; completion of enrollment in the pancreatic IMPACT study is also contributing to the discussion.

Dynex Capital, Inc. is an internally managed mortgage real estate investment trust. It engages in the business of investing in mortgage-backed securities. The company was founded on December 18, 1987 and is headquartered in Glen Allen, VA.

Dynex Capital, Inc.

Dynexs Q3 results are drawing attention after wider mortgage spreads drove a sharp decline in book value and a reported loss, while earnings fell short of covering the monthly dividend. Traders are debating dividend sustainability and added risk from higher leverage, though some view the losses as largely unrealized and continue to favor the income stream.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech selloff, attributed by traders to rising-rate concerns, risk-off positioning and rotation away from smaller biotech stocks, is weighing on XBI. The community is split between expecting further weakness and viewing the sharp pullback as an oversold buying opportunity, with potential M&A and upcoming clinical catalysts cited as reasons for optimism.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

A sharp, high-volume rebound after a steep AI-infrastructure selloff has drawn attention to WULF, with traders highlighting CEO Paul Pragers CNBC defense of its power-and-data-center leasing model, which avoids owning rapidly depreciating chips, and bullish Morgan Stanley commentary. The community is split between viewing the move as a possible reversal and worrying that financing costs, leverage, and broader sector weakness could bring renewed selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QTREX Quantum Stock Is Trending: Here's Why It Rocketed 28% After-Hours

QTREX Quantum shares surge 27.92% after hours as quantum wiring test results and deal prospects drive gains.read more...

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

Stablecoin Development (AMEX:SDEV) shares moved upwards by 66.9% to $6.11 during Friday's regular session. The company's market cap stands at $99.2 million.
QTREX Quantum (NASDAQ:QTEX) stock roseread more...

QTREX Quantum Stock Climbs Friday: What's Going On?

QTREX Quantum is trading higher Friday after announcing breakthrough quantum interconnect testing and progress toward a commercial agreement.read more...

What's Going On With QTREX Quantum Shares On Tuesday?

QTEX shares gained after QTREX Quantum announced deployment of its AME system at a leading U.S. government research laboratory.read more...

What's Going On With QTEX Quantum Stock On Tuesday?

QTREX Quantum's Additively Manufactured Electronics technology achieved a 97% yield validation at a major U.S. interconnect manufacturer.read more...

What's Going On With QTREX Quantum Stock Monday?

QTREX Quantum stock rallies to $1.70 in premarket action. Will it break past key resistance levels or pull back? Get the technical outlook.read more...

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell Technology Inc (NASDAQ: MRVL) surged in pre-market trading after securing a spot in the S&P 500...

Small-Cap Squeeze Mania Accelerates

The speculative small-cap market is once again heating up as traders aggressively rotate into companies tied to some of the market’s highest-growth narratives. Increased volatility, rising retail participation, and momentum-driven trading activity are fueling renewed attention across a wide range of low-float and emerging technology stocks. $BLIS, $KBLB, $XERI, $HUBC, $QTEX, $OLOX

QTEX Stock Boosted By A $10M Wall Street Trigger – Retail Calls It A ‘Great Signal’

Equity

Qtrex Quantum announced an agreement to sell around 6.7 million shares to an institutional investor.

Why Is QTREX Quantum Stock Surging On Thursday?

QTREX Quantum Ltd. (NASDAQ: QTEX) stock is surging on Thursday. Read how a strategic pivot and cryogenic interconnect tech drove this multi-day rally.read more...

This account has been verified as an official QTEX representative.

Verified Account

Qtrex Quantum IR

QTREX Quantum Ltd. is a specialty medical device company, which engages in research, development, manufacturing, and marketing of proprietary life support technology with a vision to supersede traditional mechanical ventilators, or Mechanical Ventilation, which is the standard of care today for the treatment of acute respiratory failure. The company was founded by Dagi Shahar Ben Noon, Joe Hayon, and Udi Nussinovitch in July 2017 and is headquartered in Raanana, Israel.

QTREX Quantum Ltd.

Bullish Sentiment

<ul class="summary-bullets"><li>The offering, which is expected to raise $10 million, will close on June 1.</li><li>Qtrex Quantum had changed its name from Inspira Technologies and began trading under a new ticker on May 20.</li><li>The rebrand marks the company’s shift from a medical care technology firm to a quantum connectivity infrastructure provider.</li></ul>Shares of Qtrex Quantum (QTEX) jumped more than 13% on Friday, before paring some of the gains, as investors piled into the newly rebranded company following a $10 million institutional investment, fueling fresh optimism about its transformation from a medical technology player into a quantum-focused venture.<a href="https://stocktwits.com/symbol/QTEX">QTEX shares</a> were up around 10% at the time of writing.<h2 class="st-heading-2">QTEX To Offer Around 6.7M Shares</h2>The company said it has signed a securities purchase agreement with a new institutional investor to sell 6.67 million ordinary shares, or equivalent securities, in a private placement deal.The offering is expected to raise about $10 million in gross proceeds, with the transaction closing around June 1. This represents a per-share value of around $1.5, a 50% discount on the stock’s closing price on Thursday.The company said it plans to use the funds for working capital and other general corporate purposes.“This financing strengthens our ability to accelerate the commercialization of our advanced electronics manufacturing (AME)-based cryogenic interconnect platform, scale our newly acquired AME capabilities, and support research and development across quantum and other mission-critical hardware applications,” said CEO Dagi Ben-Noon.<h2 class="st-heading-2">QTEX In Talks With Top Quantum Computing Firm Over Potential Partnership</h2>Previously known as Inspira Technologies, Qtrex Quantum started trading under the new Nasdaq ticker ‘QTEX’ on May 20 as part of its corporate rebranding.The rebranding reflects the company’s strategic shift toward AME and quantum connectivity infrastructure. Inspira was previously focused on respiratory care and medical technology solutions.Last week, Qtrex said it is in advanced talks with a top-five quantum computing company for a potential partnership. The companies are currently conducting technical evaluations of Qtrex’s proprietary interconnect technology for signal routing and thermal management in quantum computing systems.<h2 class="st-heading-2">Retail Says Offering Is A Bullish Signal For Things To Come</h2>Retail sentiment on Stocktwits has remained in the 'extremely bullish' zone over the past 24 hours, accompanied by 'extremely high' message volumes.One user called it a “great signal for forward-looking events.”<stembedurl>https://stocktwits.com/sierrapanda/message/654781655</stembedurl>Another user said the capital infusion meant the cash runway is extended into 2027.<stembedurl>https://stocktwits.com/ValuePlayRunners/message/654748109</stembedurl>The stock has gained more than 700% since the rebranding.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-cmnd-stock-jump-40-today/cZgSrhBReMK">Why Did CMND Stock Jump 40% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.50
Prev Close	$1.58
Open	$1.60
Dividend Yield	0.00%
50-Day Moving Average	$1.01
Beta	1.65
Avg. Volume	1.77M
PE Ratio	-4.29

52-Week High	$3.85
52-Week Low	$0.283
Market Capitalization	$100.61M
EPS (Annual)	-$0.4463
Price to Book	7.74
Revenue Per Employee	$7,225.00

Feed

News

Sentiment

Fundamentals

Info

QTEX Fundamentals